These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 3756906)

  • 21. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.
    Mujoo K; Kipps TJ; Yang HM; Cheresh DA; Wargalla U; Sander DJ; Reisfeld RA
    Cancer Res; 1989 Jun; 49(11):2857-61. PubMed ID: 2720646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo destruction of canine lymphoma mediated by murine monoclonal antibodies.
    Steplewski Z; Rosales C; Jeglum KA; McDonald-Smith J
    In Vivo; 1990; 4(4):231-4. PubMed ID: 2103365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ; Foltzer M; Chapman S
    Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
    Perera RM; Narita Y; Furnari FB; Gan HK; Murone C; Ahlkvist M; Luwor RB; Burgess AW; Stockert E; Jungbluth AA; Old LJ; Cavenee WK; Scott AM; Johns TG
    Clin Cancer Res; 2005 Sep; 11(17):6390-9. PubMed ID: 16144944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors.
    Fan Z; Shang BY; Lu Y; Chou JL; Mendelsohn J
    Clin Cancer Res; 1997 Nov; 3(11):1943-8. PubMed ID: 9815583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
    Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
    J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy of human glioma xenografts with unlabeled, 131I-, or 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor.
    Bender H; Takahashi H; Adachi K; Belser P; Liang SH; Prewett M; Schrappe M; Sutter A; Rodeck U; Herlyn D
    Cancer Res; 1992 Jan; 52(1):121-6. PubMed ID: 1727372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction.
    Reins HA; Steinhilber G; Freiberg B; Anderer FA
    J Cell Biochem; 1993 Feb; 51(2):236-48. PubMed ID: 8382707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth inhibition of human nasopharyngeal carcinoma in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
    Guan E; Zhou TC; Wang JH; Huang PG; Tang WP; Zhao ML; Chen Y; Sun YX
    Int J Cell Cloning; 1989 Jul; 7(4):242-56. PubMed ID: 2768842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
    Luwor RB; Johns TG; Murone C; Huang HJ; Cavenee WK; Ritter G; Old LJ; Burgess AW; Scott AM
    Cancer Res; 2001 Jul; 61(14):5355-61. PubMed ID: 11454674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
    Bianco C; Bianco R; Tortora G; Damiano V; Guerrieri P; Montemaggi P; Mendelsohn J; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2000 Nov; 6(11):4343-50. PubMed ID: 11106252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N; Ueda M; Ozawa S; Abe O; Shimizu N
    Cancer Res; 1989 Dec; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.
    Herlyn D; Powe J; Ross AH; Herlyn M; Koprowski H
    J Immunol; 1985 Feb; 134(2):1300-4. PubMed ID: 3965572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma.
    Basham TY; Kaminski MS; Kitamura K; Levy R; Merigan TC
    J Immunol; 1986 Nov; 137(9):3019-24. PubMed ID: 3760580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice.
    Rashid A; Auchincloss H; Sharon J
    J Immunol; 1992 Mar; 148(5):1382-8. PubMed ID: 1538121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
    Kim JA; Averbook BJ; Chambers K; Rothchild K; Kjaergaard J; Papay R; Shu S
    Cancer Res; 2001 Mar; 61(5):2031-7. PubMed ID: 11280763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen.
    Kim KM; Shin EY; Moon JH; Heo TH; Lee JY; Chung Y; Lee YJ; Cho HM; Shin SU; Kang CY
    Int J Cancer; 2002 Dec; 102(4):428-34. PubMed ID: 12402315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.